Does the media prefer BAX or AMN?

In the previous week, AMN Healthcare Services had 7 more articles in the media than Baxter International. MarketBeat recorded 20 mentions for AMN Healthcare Services and 13 mentions for Baxter International. Baxter International's average media sentiment score of 1.24 beat AMN Healthcare Services' score of 0.41 indicating that Baxter International is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Baxter International 12 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive AMN Healthcare Services 6 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer BAX or DVA?

In the previous week, DaVita had 8 more articles in the media than Baxter International. MarketBeat recorded 21 mentions for DaVita and 13 mentions for Baxter International. DaVita's average media sentiment score of 1.45 beat Baxter International's score of 1.24 indicating that DaVita is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Baxter International 12 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive DaVita 18 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to BDX or BAX?

In the previous week, Becton, Dickinson and Company had 18 more articles in the media than Baxter International. MarketBeat recorded 31 mentions for Becton, Dickinson and Company and 13 mentions for Baxter International. Becton, Dickinson and Company's average media sentiment score of 1.37 beat Baxter International's score of 1.24 indicating that Becton, Dickinson and Company is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Becton, Dickinson and Company 24 Very Positive mention(s) 4 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Baxter International 12 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor BAX or EW?

In the previous week, Edwards Lifesciences had 26 more articles in the media than Baxter International. MarketBeat recorded 39 mentions for Edwards Lifesciences and 13 mentions for Baxter International. Edwards Lifesciences' average media sentiment score of 1.53 beat Baxter International's score of 1.24 indicating that Edwards Lifesciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Baxter International 12 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Edwards Lifesciences 37 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Does the media refer more to IDXX or BAX?

In the previous week, Baxter International had 6 more articles in the media than IDEXX Laboratories. MarketBeat recorded 13 mentions for Baxter International and 7 mentions for IDEXX Laboratories. IDEXX Laboratories' average media sentiment score of 1.31 beat Baxter International's score of 1.24 indicating that IDEXX Laboratories is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment IDEXX Laboratories 4 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Baxter International 12 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Baxter International (BAX) Competitors

$26.13 0.00 (0.00%)

As of 08/28/2026 03:58 PM Eastern

Compare

BAX vs. AMN, DVA, BDX, EW, and IDXX

Should you buy Baxter International stock or one of its competitors? Baxter International's main competitors and comparable companies include AMN Healthcare Services (AMN), DaVita (DVA), Becton, Dickinson and Company (BDX), Edwards Lifesciences (EW), and IDEXX Laboratories (IDXX). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare" sector.

How does Baxter International compare to AMN Healthcare Services?

Baxter International (NYSE:BAX) and AMN Healthcare Services (NYSE:AMN) are both healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, dividends, profitability, valuation, institutional ownership, risk, earnings and analyst recommendations.

AMN Healthcare Services has a net margin of 3.06% compared to Baxter International's net margin of -9.27%. AMN Healthcare Services' return on equity of 19.92% beat Baxter International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Baxter International	-9.27%	16.57%	5.24%
AMN Healthcare Services	3.06%	19.92%	5.93%

90.2% of Baxter International shares are owned by institutional investors. Comparatively, 99.2% of AMN Healthcare Services shares are owned by institutional investors. 0.2% of Baxter International shares are owned by insiders. Comparatively, 1.1% of AMN Healthcare Services shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Baxter International has a beta of 0.59, suggesting that its stock price is 41% less volatile than the broader market. Comparatively, AMN Healthcare Services has a beta of 0.4, suggesting that its stock price is 60% less volatile than the broader market.

Baxter International presently has a consensus target price of $22.45, suggesting a potential downside of 14.07%. AMN Healthcare Services has a consensus target price of $31.43, suggesting a potential downside of 9.06%. Given AMN Healthcare Services' stronger consensus rating and higher possible upside, analysts clearly believe AMN Healthcare Services is more favorable than Baxter International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Baxter International	2 Sell rating(s)	9 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.00
AMN Healthcare Services	2 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.22

AMN Healthcare Services has lower revenue, but higher earnings than Baxter International. Baxter International is trading at a lower price-to-earnings ratio than AMN Healthcare Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Baxter International	$11.24B	1.20	-$957M	-$2.07	N/A
AMN Healthcare Services	$3.43B	0.39	-$95.70M	$2.68	12.90

Baxter International pays an annual dividend of $0.04 per share and has a dividend yield of 0.2%. AMN Healthcare Services pays an annual dividend of $1.20 per share and has a dividend yield of 3.5%. Baxter International pays out -1.9% of its earnings in the form of a dividend. AMN Healthcare Services pays out 44.8% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

In the previous week, AMN Healthcare Services had 7 more articles in the media than Baxter International. MarketBeat recorded 20 mentions for AMN Healthcare Services and 13 mentions for Baxter International. Baxter International's average media sentiment score of 1.24 beat AMN Healthcare Services' score of 0.41 indicating that Baxter International is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Baxter International	12 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
AMN Healthcare Services	6 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

AMN Healthcare Services beats Baxter International on 13 of the 18 factors compared between the two stocks.

How does Baxter International compare to DaVita?

Baxter International (NYSE:BAX) and DaVita (NYSE:DVA) are both large-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, risk, profitability, earnings, analyst recommendations, media sentiment, institutional ownership and valuation.

Baxter International presently has a consensus target price of $22.45, indicating a potential downside of 14.07%. DaVita has a consensus target price of $221.75, indicating a potential upside of 22.70%. Given DaVita's stronger consensus rating and higher possible upside, analysts plainly believe DaVita is more favorable than Baxter International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Baxter International	2 Sell rating(s)	9 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.00
DaVita	1 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.38

Baxter International has a beta of 0.59, suggesting that its share price is 41% less volatile than the broader market. Comparatively, DaVita has a beta of 0.88, suggesting that its share price is 12% less volatile than the broader market.

DaVita has a net margin of 6.05% compared to Baxter International's net margin of -9.27%. Baxter International's return on equity of 16.57% beat DaVita's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Baxter International	-9.27%	16.57%	5.24%
DaVita	6.05%	-217.63%	5.07%

DaVita has higher revenue and earnings than Baxter International. Baxter International is trading at a lower price-to-earnings ratio than DaVita, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Baxter International	$11.24B	1.20	-$957M	-$2.07	N/A
DaVita	$13.64B	0.85	$746.80M	$12.22	14.79

90.2% of Baxter International shares are owned by institutional investors. Comparatively, 90.1% of DaVita shares are owned by institutional investors. 0.2% of Baxter International shares are owned by company insiders. Comparatively, 1.9% of DaVita shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

In the previous week, DaVita had 8 more articles in the media than Baxter International. MarketBeat recorded 21 mentions for DaVita and 13 mentions for Baxter International. DaVita's average media sentiment score of 1.45 beat Baxter International's score of 1.24 indicating that DaVita is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Baxter International	12 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
DaVita	18 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

DaVita beats Baxter International on 12 of the 16 factors compared between the two stocks.

How does Baxter International compare to Becton, Dickinson and Company?

Becton, Dickinson and Company (NYSE:BDX) and Baxter International (NYSE:BAX) are both large-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, media sentiment, analyst recommendations, profitability, risk, dividends and earnings.

Becton, Dickinson and Company presently has a consensus price target of $185.67, indicating a potential downside of 2.13%. Baxter International has a consensus price target of $22.45, indicating a potential downside of 14.07%. Given Becton, Dickinson and Company's stronger consensus rating and higher probable upside, research analysts clearly believe Becton, Dickinson and Company is more favorable than Baxter International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Becton, Dickinson and Company	1 Sell rating(s)	8 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.41
Baxter International	2 Sell rating(s)	9 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, Becton, Dickinson and Company had 18 more articles in the media than Baxter International. MarketBeat recorded 31 mentions for Becton, Dickinson and Company and 13 mentions for Baxter International. Becton, Dickinson and Company's average media sentiment score of 1.37 beat Baxter International's score of 1.24 indicating that Becton, Dickinson and Company is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Becton, Dickinson and Company	24 Very Positive mention(s)	4 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Baxter International	12 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

87.0% of Becton, Dickinson and Company shares are owned by institutional investors. Comparatively, 90.2% of Baxter International shares are owned by institutional investors. 0.4% of Becton, Dickinson and Company shares are owned by company insiders. Comparatively, 0.2% of Baxter International shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Becton, Dickinson and Company has a beta of 0.19, meaning that its stock price is 81% less volatile than the broader market. Comparatively, Baxter International has a beta of 0.59, meaning that its stock price is 41% less volatile than the broader market.

Becton, Dickinson and Company has higher revenue and earnings than Baxter International. Baxter International is trading at a lower price-to-earnings ratio than Becton, Dickinson and Company, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Becton, Dickinson and Company	$21.84B	2.39	$1.68B	$3.32	57.14
Baxter International	$11.24B	1.20	-$957M	-$2.07	N/A

Becton, Dickinson and Company has a net margin of 4.52% compared to Baxter International's net margin of -9.27%. Baxter International's return on equity of 16.57% beat Becton, Dickinson and Company's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Becton, Dickinson and Company	4.52%	14.79%	6.93%
Baxter International	-9.27%	16.57%	5.24%

Becton, Dickinson and Company pays an annual dividend of $4.20 per share and has a dividend yield of 2.2%. Baxter International pays an annual dividend of $0.04 per share and has a dividend yield of 0.2%. Becton, Dickinson and Company pays out 126.5% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Baxter International pays out -1.9% of its earnings in the form of a dividend. Becton, Dickinson and Company has raised its dividend for 53 consecutive years. Becton, Dickinson and Company is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Summary

Becton, Dickinson and Company beats Baxter International on 15 of the 19 factors compared between the two stocks.

How does Baxter International compare to Edwards Lifesciences?

Baxter International (NYSE:BAX) and Edwards Lifesciences (NYSE:EW) are both large-cap healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, valuation, analyst recommendations, earnings, risk, institutional ownership, profitability and dividends.

Edwards Lifesciences has a net margin of 15.43% compared to Baxter International's net margin of -9.27%. Baxter International's return on equity of 16.57% beat Edwards Lifesciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Baxter International	-9.27%	16.57%	5.24%
Edwards Lifesciences	15.43%	15.68%	12.05%

Baxter International currently has a consensus target price of $22.45, indicating a potential downside of 14.07%. Edwards Lifesciences has a consensus target price of $100.27, indicating a potential upside of 11.18%. Given Edwards Lifesciences' stronger consensus rating and higher probable upside, analysts plainly believe Edwards Lifesciences is more favorable than Baxter International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Baxter International	2 Sell rating(s)	9 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.00
Edwards Lifesciences	0 Sell rating(s)	6 Hold rating(s)	17 Buy rating(s)	0 Strong Buy rating(s)	2.74

90.2% of Baxter International shares are held by institutional investors. Comparatively, 79.5% of Edwards Lifesciences shares are held by institutional investors. 0.2% of Baxter International shares are held by company insiders. Comparatively, 0.3% of Edwards Lifesciences shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Baxter International has a beta of 0.59, meaning that its share price is 41% less volatile than the broader market. Comparatively, Edwards Lifesciences has a beta of 0.85, meaning that its share price is 15% less volatile than the broader market.

Edwards Lifesciences has lower revenue, but higher earnings than Baxter International. Baxter International is trading at a lower price-to-earnings ratio than Edwards Lifesciences, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Baxter International	$11.24B	1.20	-$957M	-$2.07	N/A
Edwards Lifesciences	$6.07B	8.56	$1.07B	$1.74	51.83

In the previous week, Edwards Lifesciences had 26 more articles in the media than Baxter International. MarketBeat recorded 39 mentions for Edwards Lifesciences and 13 mentions for Baxter International. Edwards Lifesciences' average media sentiment score of 1.53 beat Baxter International's score of 1.24 indicating that Edwards Lifesciences is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Baxter International	12 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Edwards Lifesciences	37 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Summary

Edwards Lifesciences beats Baxter International on 13 of the 16 factors compared between the two stocks.

How does Baxter International compare to IDEXX Laboratories?

IDEXX Laboratories (NASDAQ:IDXX) and Baxter International (NYSE:BAX) are both large-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, media sentiment, profitability, risk, analyst recommendations, dividends, institutional ownership and valuation.

IDEXX Laboratories has a net margin of 25.03% compared to Baxter International's net margin of -9.27%. IDEXX Laboratories' return on equity of 71.96% beat Baxter International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IDEXX Laboratories	25.03%	71.96%	33.60%
Baxter International	-9.27%	16.57%	5.24%

In the previous week, Baxter International had 6 more articles in the media than IDEXX Laboratories. MarketBeat recorded 13 mentions for Baxter International and 7 mentions for IDEXX Laboratories. IDEXX Laboratories' average media sentiment score of 1.31 beat Baxter International's score of 1.24 indicating that IDEXX Laboratories is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
IDEXX Laboratories	4 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Baxter International	12 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

IDEXX Laboratories presently has a consensus target price of $747.00, indicating a potential upside of 34.60%. Baxter International has a consensus target price of $22.45, indicating a potential downside of 14.07%. Given IDEXX Laboratories' stronger consensus rating and higher probable upside, equities analysts plainly believe IDEXX Laboratories is more favorable than Baxter International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IDEXX Laboratories	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.60
Baxter International	2 Sell rating(s)	9 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.00

IDEXX Laboratories has a beta of 1.54, meaning that its stock price is 54% more volatile than the broader market. Comparatively, Baxter International has a beta of 0.59, meaning that its stock price is 41% less volatile than the broader market.

IDEXX Laboratories has higher earnings, but lower revenue than Baxter International. Baxter International is trading at a lower price-to-earnings ratio than IDEXX Laboratories, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IDEXX Laboratories	$4.55B	9.60	$1.06B	$14.22	39.03
Baxter International	$11.24B	1.20	-$957M	-$2.07	N/A

87.8% of IDEXX Laboratories shares are owned by institutional investors. Comparatively, 90.2% of Baxter International shares are owned by institutional investors. 0.8% of IDEXX Laboratories shares are owned by insiders. Comparatively, 0.2% of Baxter International shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Summary

IDEXX Laboratories beats Baxter International on 13 of the 16 factors compared between the two stocks.

Get Baxter International News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BAX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

BAX vs. The Competition

Export

Metric	Baxter International	Healthcare Equipment & Supplies Industry	Healthcare Sector	NYSE Exchange
Market Cap	$13.51B	$5.88B	$7.21B	$24.18B
Dividend Yield	0.15%	1.75%	2.54%	3.72%
P/E Ratio	-12.62	25.92	273.16	30.01
Price / Sales	1.20	79.04	635.16	23.58
Price / Cash	4.60	33.69	28.74	19.75
Price / Book	2.20	6.18	11.08	4.84
Net Income	-$957M	$149.94M	$3.48B	$1.07B
7 Day Performance	-1.40%	-0.22%	0.38%	-0.41%
1 Month Performance	-0.27%	6.39%	7.89%	2.04%
1 Year Performance	5.73%	6.29%	24.71%	13.37%

Baxter International Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
BAX Baxter International	2.0499 of 5 stars	$26.13 flat	$22.45 -14.1%	+5.7%	$13.51B	$11.24B	N/A	37,500	Positive News
AMN AMN Healthcare Services	2.1987 of 5 stars	$34.50 +0.1%	$31.43 -8.9%	+66.4%	$1.33B	$2.73B	12.87	2,664	Analyst Downgrade Analyst Revision
DVA DaVita	4.9481 of 5 stars	$176.54 +1.6%	$221.75 +25.6%	+31.2%	$11.09B	$13.64B	14.45	78,000	News Coverage Positive News
BDX Becton, Dickinson and Company	3.617 of 5 stars	$190.58 -0.7%	$185.67 -2.6%	-1.6%	$52.90B	$21.84B	57.40	72,000	News Coverage Positive News
EW Edwards Lifesciences	3.829 of 5 stars	$90.54 +0.8%	$100.27 +10.8%	+10.7%	$51.70B	$6.07B	52.03	16,000	Positive News Insider Trade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:BAX) was last updated on 8/31/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Baxter International (BAX) Competitors

BAX vs. AMN, DVA, BDX, EW, and IDXX

How does Baxter International compare to AMN Healthcare Services?

Summary

How does Baxter International compare to DaVita?

Summary

How does Baxter International compare to Becton, Dickinson and Company?

Summary

How does Baxter International compare to Edwards Lifesciences?

Summary

How does Baxter International compare to IDEXX Laboratories?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BAX vs. The Competition

Baxter International Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Baxter International (BAX) Competitors

BAX vs. AMN, DVA, BDX, EW, and IDXX

How does Baxter International compare to AMN Healthcare Services?

Is BAX or AMN more profitable?

Do insiders and institutionals hold more shares of BAX or AMN?

Which has more risk and volatility, BAX or AMN?

Do analysts rate BAX or AMN?

Which has better earnings and valuation, BAX or AMN?

Is BAX or AMN a better dividend stock?

Does the media prefer BAX or AMN?

Summary

How does Baxter International compare to DaVita?

Do analysts rate BAX or DVA?

Which has more volatility & risk, BAX or DVA?

Is BAX or DVA more profitable?

Which has stronger earnings and valuation, BAX or DVA?

Do institutionals & insiders believe in BAX or DVA?

Does the media prefer BAX or DVA?

Summary

How does Baxter International compare to Becton, Dickinson and Company?

Do analysts prefer BDX or BAX?

Does the media refer more to BDX or BAX?

Do insiders & institutionals have more ownership in BDX or BAX?

Which has more risk and volatility, BDX or BAX?

Which has stronger valuation and earnings, BDX or BAX?

Is BDX or BAX more profitable?

Is BDX or BAX a better dividend stock?

Summary

How does Baxter International compare to Edwards Lifesciences?

Is BAX or EW more profitable?

Do analysts recommend BAX or EW?

Do insiders and institutionals have more ownership in BAX or EW?

Which has more volatility and risk, BAX or EW?

Which has better earnings & valuation, BAX or EW?

Does the media favor BAX or EW?

Summary

How does Baxter International compare to IDEXX Laboratories?

Is IDXX or BAX more profitable?

Does the media refer more to IDXX or BAX?

Do analysts rate IDXX or BAX?

Which has more risk & volatility, IDXX or BAX?

Which has better valuation & earnings, IDXX or BAX?

Do institutionals and insiders have more ownership in IDXX or BAX?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

BAX vs. The Competition

Baxter International Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools